White matter changes in breast cancer brain metastases patients who undergo radiosurgery alone compared to whole brain radiation therapy plus radiosurgery

Journal of Neuro-Oncology

Volumn 121, Issue 3, 2015, Pages 583-590

  Stokes, Timothy B ^a   Niranjan, Ajay ^a   Kano, Hideyuki ^a   Choi, Phillip A ^a   Kondziolka, Douglas ^b   Dade Lunsford, L ^a   Monaco, Edward A ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brain metastasis; Breast cancer; Gamma Knife; Leukoencephalopathy; Stereotactic radiosurgery

Indexed keywords

ADULT; ARTICLE; BRAIN METASTASIS; BRAIN VENTRICLE; BREAST CANCER; CANCER RADIOTHERAPY; FEMALE; GAMMA KNIFE RADIOSURGERY; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL BODY RADIATION; RADIATION DOSE; RETROSPECTIVE STUDY; RISK ASSESSMENT; WHITE MATTER; WHITE MATTER INJURY; WHOLE BRAIN RADIOTHERAPY; ADVERSE EFFECTS; BRAIN NEOPLASMS; BREAST NEOPLASMS; COMPARATIVE STUDY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; RADIATION INJURY; RADIATION RESPONSE; RADIOSURGERY; SECONDARY; SKULL IRRADIATION;

BRAIN NEOPLASMS; BREAST NEOPLASMS; CRANIAL IRRADIATION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; RADIATION INJURIES; RADIOSURGERY; WHITE MATTER;

EID: 84925491803     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-014-1670-4     Document Type: Article

References (50)

1. Patchell RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ, Markesbery WR, Foon KA, Young B (1998) Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280:1485–1489. doi:10.1001/jama.280.17.1485
2. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483–2491. doi:10.1001/jama.295.21.2483
3. Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller RP (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 29:134–141. doi:10.1200/JCO.2010.30.1655
4. Hall WA, Djalilian HR, Nussbaum ES, Cho KH (2000) Long-term survival with metastatic cancer to the brain. Med Oncol 17:279–286
5. Kondziolka D, Martin JJ, Flickinger JC, Friedland DM, Brufsky AM, Baar J, Agarwala S, Kirkwood JM, Lunsford LD (2005) Long-term survivors after gamma knife radiosurgery for brain metastases. Cancer 104:2784–2791. doi:10.1002/cncr.21545
6. Altundag K, Bondy ML, Mirza NQ, Kau SW, Broglio K, Hortobagyi GN, Rivera E (2007) Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis. Cancer 110:2640–2647. doi:10.1002/cncr.23088
7. Burger PC, Mahley MS Jr, Dudka L, Vogel FS (1979) The morphologic effects of radiation administered therapeutically for intracranial gliomas: a postmortem study of 25 cases. Cancer 44:1256–1272
8. Hopewell JW (1979) Late radiation damage to the central nervous system: a radiobiological interpretation. Neuropathol Appl Neurobiol 5:329–343
9. Tiller-Borcich JK, Fike JR, Phillips TL, Davis RL (1987) Pathology of delayed radiation brain damage: an experimental canine model. Radiat Res 110:161–172
10. Panagiotakos G, Alshamy G, Chan B, Abrams R, Greenberg E, Saxena A, Bradbury M, Edgar M, Gutin P, Tabar V (2007) Long-term impact of radiation on the stem cell and oligodendrocyte precursors in the brain. PLoS One 2:e588. doi:10.1371/journal.pone.0000588
11. Defrancesco M, Marksteiner J, Deisenhammer E, Kemmler G, Djurdjevic T, Schocke M (2013) Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer’s disease. J Alzheimers Dis 34:665–672. doi:10.3233/JAD-122095
12. Pfefferbaum A, Rosenbloom M, Rohlfing T, Sullivan EV (2009) Degradation of association and projection white matter systems in alcoholism detected with quantitative fiber tracking. Biol Psychiatry 65:680–690. doi:10.1016/j.biopsych.2008.10.039
13. Hulst HE, Steenwijk MD, Versteeg A, Pouwels PJ, Vrenken H, Uitdehaag BM, Polman CH, Geurts JJ, Barkhof F (2013) Cognitive impairment in MS: impact of white matter integrity, gray matter volume, and lesions. Neurology 80:1025–1032. doi:10.1212/WNL.0b013e31828726cc
14. Fujii O, Tsujino K, Soejima T, Yoden E, Ichimiya Y, Sugimura K (2006) White matter changes on magnetic resonance imaging following whole-brain radiotherapy for brain metastases. Radiat Med 24:345–350. doi:10.1007/s11604-006-0039-9
15. Szerlip N, Rutter C, Ram N, Yovino S, Kwok Y, Maggio W, Regine WF (2011) Factors impacting volumetric white matter changes following whole brain radiation therapy. J Neurooncol 103:111–119. doi:10.1007/s11060-010-0358-7
16. Ebi J, Sato H, Nakajima M, Shishido F (2013) Incidence of leukoencephalopathy after whole-brain radiation therapy for brain metastases. Int J Radiat Oncol Biol Phys 85:1212–1217. doi:10.1016/j.ijrobp.2012.09.025
17. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:1037–1044. doi:10.1016/S1470-2045(09)70263-3
18. Monaco EA 3rd, Faraji AH, Berkowitz O, Parry PV, Hadelsberg U, Kano H, Niranjan A, Kondziolka D, Lunsford LD (2013) Leukoencephalopathy after whole-brain radiation therapy plus radiosurgery versus radiosurgery alone for metastatic lung cancer. Cancer 119:226–232. doi:10.1002/cncr.27504
19. Sperduto PW, Kased N, Roberge D, Chao ST, Shanley R, Luo X, Sneed PK, Suh J, Weil RJ, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JP, Sperduto CM, Lin N, Mehta M (2013) The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer. J Neurooncol 112:467–472. doi:10.1007/s11060-013-1083-9
20. Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC (1999) Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 45:427–434
21. Tsuruda JS, Kortman KE, Bradley WG, Wheeler DC, Van Dalsem W, Bradley TP (1987) Radiation effects on cerebral white matter: MR evaluation. AJR Am J Roentgenol 149:165–171. doi:10.2214/ajr.149.1.165
22. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA (1987) MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol 149:351–356. doi:10.2214/ajr.149.2.351
23. Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI (1999) Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 43:795–803
24. Nieder C, Nestle U, Motaref B, Walter K, Niewald M, Schnabel K (2000) Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes? Int J Radiat Oncol Biol Phys 46:297–302
25. Borgelt B, Gelber R, Kramer S, Brady LW, Chang CH, Davis LW, Perez CA, Hendrickson FR (1980) The palliation of brain metastases: final results of the first two studies by the radiation therapy oncology group. Int J Radiat Oncol Biol Phys 6:1–9
26. Borgelt B, Gelber R, Larson M, Hendrickson F, Griffin T, Roth R (1981) Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: final results of the first two studies by the radiation therapy oncology group. Int J Radiat Oncol Biol Phys 7:1633–1638
27. Komarnicky LT, Phillips TL, Martz K, Asbell S, Isaacson S, Urtasun R (1991) A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). Int J Radiat Oncol Biol Phys 20:53–58
28. Phillips TL, Scott CB, Leibel SA, Rotman M, Weigensberg IJ (1995) Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89-05. Int J Radiat Oncol Biol Phys 33:339–348. doi:10.1016/0360-3016(95)00168-X
29. Brown PD, Pugh S, Laack NN, Wefel JS, Khuntia D, Meyers C, Choucair A, Fox S, Suh JH, Roberge D, Kavadi V, Bentzen SM, Mehta MP, Watkins-Bruner D, Radiation Therapy Oncology G (2013) Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro Oncol 15:1429–1437. doi:10.1093/neuonc/not114
30. Nieder C, Spanne O, Mehta MP, Grosu AL, Geinitz H (2011) Presentation, patterns of care, and survival in patients with brain metastases: what has changed in the last 20 years? Cancer 117:2505–2512. doi:10.1002/cncr.25707
31. Rades D, Schild SE (2012) Do patients with a limited number of brain metastases need whole-brain radiotherapy in addition to radiosurgery? Strahlenther Onkol 188:702–706. doi:10.1007/s00066-012-0093-4
32. Soffietti R, Kocher M, Abacioglu UM, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Mueller RP, Tridello G, Collette L, Bottomley A (2013) A European organisation for research and treatment of cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol 31:65–72. doi:10.1200/JCO.2011.41.0639
33. Conill C, Berenguer J, Vargas M, Lopez-Soriano A, Valduvieco I, Marruecos J, Vilella R (2007) Incidence of radiation-induced leukoencephalopathy after whole brain radiotherapy in patients with brain metastases. Clin Transl Oncol 9:590–595
34. Chawla S, Wang S, Kim S, Sheriff S, Lee P, Rengan R, Lin A, Melhem E, Maudsley A, Poptani H (2013) Radiation injury to the normal brain measured by 3D-echo-planar spectroscopic imaging and diffusion tensor imaging: initial experience. J Neuroimaging. doi:10.1111/jon.12070
35. Lao CD, Friedman J, Tsien CI, Normolle DP, Chapman C, Cao Y, Lee O, Schipper M, Van Poznak C, Hamstra D, Lawrence T, Hayman J, Redman BG (2013) Concurrent whole brain radiotherapy and bortezomib for brain metastasis. Radiat Oncol 8:204. doi:10.1186/1748-717X-8-204
36. Sheehan JP, Sun MH, Kondziolka D, Flickinger J, Lunsford LD (2002) Radiosurgery for non-small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control. J Neurosurg 97:1276–1281. doi:10.3171/jns.2002.97.6.1276
37. Monaco E 3rd, Kondziolka D, Mongia S, Niranjan A, Flickinger JC, Lunsford LD (2008) Management of brain metastases from ovarian and endometrial carcinoma with stereotactic radiosurgery. Cancer 113:2610–2614. doi:10.1002/cncr.23868
38. Kano H, Iyer A, Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD (2011) Outcome predictors of gamma knife radiosurgery for renal cell carcinoma metastases. Neurosurgery 69:1232–1239. doi:10.1227/NEU.0b013e31822b2fdc
39. Kondziolka D, Kano H, Harrison GL, Yang HC, Liew DN, Niranjan A, Brufsky AM, Flickinger JC, Lunsford LD (2011) Stereotactic radiosurgery as primary and salvage treatment for brain metastases from breast cancer. Clinical article. J Neurosurg 114:792–800. doi:10.3171/2010.8.JNS10461
40. Liew DN, Kano H, Kondziolka D, Mathieu D, Niranjan A, Flickinger JC, Kirkwood JM, Tarhini A, Moschos S, Lunsford LD (2011) Outcome predictors of Gamma Knife surgery for melanoma brain metastases: clinical article. J Neurosurg 114:769–779. doi:10.3171/2010.5.JNS1014
41. Tooze A, Hiles CL, Sheehan JP (2012) Neurocognitive changes in pituitary adenoma patients after gamma knife radiosurgery: a preliminary study. World Neurosurg 78:122–128. doi:10.1016/j.wneu.2011.09.010S1878-8750(11)01089-8
42. Zimm S, Wampler GL, Stablein D, Hazra T, Young HF (1981) Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer 48:384–394
43. Pegram M, Liao J (2012) Trastuzumab treatment in multiple lines: current data and future directions. Clin Breast Cancer 12:10–18. doi:10.1016/j.clbc.2011.07.003S1526-8209(11)00155-8
44. Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD (2005) Radiosurgery with or without whole-brain radiotherapy for brain metastases: the patients’ perspective regarding complications. Am J Clin Oncol 28:173–179 00000421-200504000-00014
45. Ahles TA, Saykin AJ (2007) Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 7:192–201. doi:10.1038/nrc2073
46. Meyers CA, Smith JA, Bezjak A, Mehta MP, Liebmann J, Illidge T, Kunkler I, Caudrelier JM, Eisenberg PD, Meerwaldt J, Siemers R, Carrie C, Gaspar LE, Curran W, Phan SC, Miller RA, Renschler MF (2004) Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 22:157–165. doi:10.1200/JCO.2004.05.128
47. Aoyama H, Tago M, Kato N, Toyoda T, Kenjyo M, Hirota S, Shioura H, Inomata T, Kunieda E, Hayakawa K, Nakagawa K, Kobashi G, Shirato H (2007) Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 68:1388–1395. doi:10.1016/j.ijrobp.2007.03.048
48. Lyu J, Lee SH (2012) Gender differences in the link between excessive drinking and domain-specific cognitive functioning among older adults. J Aging Health 24:1380–1398. doi:10.1177/0898264312459346
49. Alfonso-Loeches S, Pascual M, Guerri C (2013) Gender differences in alcohol-induced neurotoxicity and brain damage. Toxicology 311:27–34. doi:10.1016/j.tox.2013.03.001S0300-483X(13)00063-2
50. Baschnagel AM, Meyer KD, Chen PY, Krauss DJ, Olson RE, Pieper DR, Maitz AH, Ye H, Grills IS (2013) Tumor volume as a predictor of survival and local control in patients with brain metastases treated with gamma knife surgery. J Neurosurg 119:1139–1144. doi:10.3171/2013.7.JNS13431